Accelerating Biologics Discovery & Development Through Transformative Technologies & Overcoming Strategic Challenges
A concise report featuring insights from the prominent thought leaders of Biologics 2024
Exploring Innovative Approaches Throughout the CGT Development Journey
A Concise Report Featuring Insights From The Prominent Thought Leaders Of Cell UK
Unlocking the Future of Immune Cancer Therapy
A concise report featuring insights from the prominent though leaders of Immuno 2024.
Senti Streamline Their CAR-NK Cell Therapy Program to Focus on Acute Myeloid Leukaemia
By dropping down from three to two ongoing cell therapies in clinical development, Senti aims to ensure its current financial reserves last into 2024.
Antibody & Protein Engineering
No More Hold-Ups: FDA Lifts Hold on Parkinson’s Drug
The FDA has repealed the hold placed on clinical trials for the Parkinson’s drug IkT-148009, which began in November.
Gene Therapy Development
Fortunes Brighten for Bluebird Bio as Cash Runway Extended to 2024
After a rocky year, bluebird bio's approval journey for a treatment for sickle cell disease looks to be back on track, with the company generating more funds by selling shares.
Immuno-Oncology
AI-Guided Personalised Cancer Vaccine Designated Fast Track by FDA
Evaxion Biotech uses AI to personalise cancer vaccines for patients’ specific tumours.
Immuno-Oncology
Teon Tx and MSD Partner in Oral IO Clinical Trial
Teon Tx and MSD will partner to study a combination of a new immune-modifier and existing anti-PD-1 immune checkpoint inhibitor.
The Race for an RSV Vaccine Approval
Things are heating up in the race to pinch the first FDA approval of an RSV vaccine, as Moderna joins Pfizer and GSK in the running.
Funding Boost Announced for Experimental Cancer Medicine Centres
Potential treatments which may benefit from the funding increase include CAR-T cell therapies and checkpoint inhibitors, with the end goal of clinical use in cancer patients.
Immuno-Oncology
New Funding Given to Network of Experimental Cancer Medicine Centres
The ECMC network will enter new partnerships to increase the availability of clinical trials for cancer patients.
Antibody & Protein Engineering
FDA Grant Approval for Alzheimer's Drug Leqembi
The US regulators have approved Eisai and Biogen’s Alzheimer’s drug, lecanemab, a “landmark” moment for the disease.
Peptide Chemistry
The Future of Peptide Chemistry and Sustainability
The peptide market is continually developing, but how are manufacturers responding to its new requirements and altering the landscape of peptide manufacturing?
Immuno-Oncology
Approaches to Combinational Immunotherapies: From Clinic to Approval
Our panel discussing combination therapeutics addresses challenges, modelling, and the importance of biomarkers.
Good Manufacturing Practices: Overcoming Regulatory Approval Hurdles
Securing regulatory approval is often the end goal in the development of a new therapeutic product. But what steps can be taken to avoid some of the common curveballs encountered in the industry?